TianLong Solution Facilitates the Prevention and Control of Livestock Diseases
By LabMedica International staff writers Posted on 21 Dec 2023 |

Image: Solution for livestock disease detection (Photo courtesy of TianLong)
It was recently announced that TianLong Science and Technology Co., Ltd. (Shaanxi, China) complies with the requirements of Chinese Good Manufacturing Practices for animal drugs. This approval further ensures TianLong's focus on standardized workflows in the development of animal products.
TianLong Solution for Livestock Disease Detection
Over the last 26 years, TianLong Technology has been committed to delivering all-encompassing solutions for molecular diagnostics and genetic testing. In the field of livestock husbandry, TianLong provides pioneering disease detection solutions, comprising a variety of instruments and matching reagents that allow for swift and reliable detection of swine fever, African swine fever, porcine reproductive and respiratory syndrome, porcine viral diarrhea, foot-and-mouth disease, and avian influenza, among others.
TianLong's livestock disease detection solution comprises a range of instruments including GeneRotex 96 Nucleic Acid Extractor, Libex Nucleic Acid Extractor, Gentier 96E/96R Real-Time PCR System, and Gentier Mini Series Portable Real-Time PCR System. These instruments exhibit outstanding performance in pathogene nucleic acid detection, guaranteeing the ability to quickly obtain precise, stable, and reliable outcomes, which enhances detection efficiency significantly. Multiple throughput can also meet various detection quantity requirements.
Alongside instruments, TianLong's compatible nucleic acid extraction and PCR detection kits have also played a crucial part in detecting livestock diseases in many countries. In Southeast Asia, TianLong partnered with top agribusiness and food groups to undertake livestock disease detection. The process involved the use of TianLong's Animal Virus DNA and RNA Extraction Kit, and African Swine Fever Virus (ASFV) Nucleic Acid Detection Kit (Fluorescence PCR Method). Both kits demonstrate exceptional performance in a wider range of sample types and higher sensitivity. When used in conjunction with TianLong's instruments, it has capacity to detect large sample volume hence increase the detection rate of low concentration samples.
In China, TianLong's avian influenza detection products have been utilized effectively by Centers for Disease Control and Prevention (CDCs), animal epidemic control agencies, and medical institutions during numerous avian influenza epidemics. Furthermore, TianLong's Avian Influenza Virus H7N9 Nucleic Acid Detection Kit (Fluorescence PCR Method), which includes the detection of both LPAI and HPAI, has gained attention in an animal disease testing laboratory in the Philippines due to its exceptional performance.
To ensure adherence to strict quality standards, TianLong has implemented a comprehensive quality management system. With ISO 13485 and ISO 9001 certifications, alongside standardized GMP product line for animal drugs, the company's focus on standardized workflows ensures the production of top-quality products.
At present, TianLong's products have been extensively used in more than 100 countries and regions globally, providing robust assistance in the prevention and control of livestock husbandry epidemics. In the future, TianLong will continuously strive to engage in research and development to contribute its scientific and technological expertise.
About TianLong
TianLong is an innovative high-tech company specializing in molecular diagnostic products in China. Since its foundation in 1997, TianLong has devoted itself to providing integrated PCR lab solutions for professionals worldwide. We have a wide range of products covering from devices to reagents, including nucleic acid extractors, Real-time PCR systems, All-in-one molecular diagnosis systems, sample processing systems, liquid handling systems, and 300 kinds of compatible reagents. With NMPA, CE, and FDA listing, our products have been exported to more than 100 countries and regions worldwide and have greatly helped the prevention and control of epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever.
For product or corporate information inquiries may be directed to inquiry@medtl.com
TianLong Solution for Livestock Disease Detection
Over the last 26 years, TianLong Technology has been committed to delivering all-encompassing solutions for molecular diagnostics and genetic testing. In the field of livestock husbandry, TianLong provides pioneering disease detection solutions, comprising a variety of instruments and matching reagents that allow for swift and reliable detection of swine fever, African swine fever, porcine reproductive and respiratory syndrome, porcine viral diarrhea, foot-and-mouth disease, and avian influenza, among others.
TianLong's livestock disease detection solution comprises a range of instruments including GeneRotex 96 Nucleic Acid Extractor, Libex Nucleic Acid Extractor, Gentier 96E/96R Real-Time PCR System, and Gentier Mini Series Portable Real-Time PCR System. These instruments exhibit outstanding performance in pathogene nucleic acid detection, guaranteeing the ability to quickly obtain precise, stable, and reliable outcomes, which enhances detection efficiency significantly. Multiple throughput can also meet various detection quantity requirements.
Alongside instruments, TianLong's compatible nucleic acid extraction and PCR detection kits have also played a crucial part in detecting livestock diseases in many countries. In Southeast Asia, TianLong partnered with top agribusiness and food groups to undertake livestock disease detection. The process involved the use of TianLong's Animal Virus DNA and RNA Extraction Kit, and African Swine Fever Virus (ASFV) Nucleic Acid Detection Kit (Fluorescence PCR Method). Both kits demonstrate exceptional performance in a wider range of sample types and higher sensitivity. When used in conjunction with TianLong's instruments, it has capacity to detect large sample volume hence increase the detection rate of low concentration samples.
In China, TianLong's avian influenza detection products have been utilized effectively by Centers for Disease Control and Prevention (CDCs), animal epidemic control agencies, and medical institutions during numerous avian influenza epidemics. Furthermore, TianLong's Avian Influenza Virus H7N9 Nucleic Acid Detection Kit (Fluorescence PCR Method), which includes the detection of both LPAI and HPAI, has gained attention in an animal disease testing laboratory in the Philippines due to its exceptional performance.
To ensure adherence to strict quality standards, TianLong has implemented a comprehensive quality management system. With ISO 13485 and ISO 9001 certifications, alongside standardized GMP product line for animal drugs, the company's focus on standardized workflows ensures the production of top-quality products.
At present, TianLong's products have been extensively used in more than 100 countries and regions globally, providing robust assistance in the prevention and control of livestock husbandry epidemics. In the future, TianLong will continuously strive to engage in research and development to contribute its scientific and technological expertise.
About TianLong
TianLong is an innovative high-tech company specializing in molecular diagnostic products in China. Since its foundation in 1997, TianLong has devoted itself to providing integrated PCR lab solutions for professionals worldwide. We have a wide range of products covering from devices to reagents, including nucleic acid extractors, Real-time PCR systems, All-in-one molecular diagnosis systems, sample processing systems, liquid handling systems, and 300 kinds of compatible reagents. With NMPA, CE, and FDA listing, our products have been exported to more than 100 countries and regions worldwide and have greatly helped the prevention and control of epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever.
For product or corporate information inquiries may be directed to inquiry@medtl.com
Latest Focus News
- CACLP Announces New Date and Venue for the Highly Anticipated 2025 Event
- Join TianLong at ADLM 2024 to Explore the Latest Diagnostic Innovations!
- Tianlong was Showcased in the METROLOGIA LAB SUMMIT and the SBBQ 53rd Annual Meeting in Brazil with Integrated PCR Lab Solutions
- Tianlong’s Latest All-in-one Molecular Diagnosis system - Panall 8000 Open System
- Meet TianLong at the 73rd Annual Convention of Philippine Society of Pathologist
- TianLong Participated in the International Medical Congress of SCO Countries in Kyrgyzstan
- TianLong HPV Nucleic Acid Detection Kit Could Enable Early Detection of Cervical Cancer
- Meet TianLong’s NEWLY LAUNCHED Real-Time PCR System - Gentier X3 Series
- TianLong Solution Facilitates the Prevention and Control of Livestock Diseases
- Tianlong Showcases Latest Real-Time PCR System and Innovative Molecular Diagnostic Solutions at MEDICA 2023
- TianLong Will Exhibit at MEDICA 2023 in Messe Düsseldorf of Germany
- Tianlong at PhilMedical 2023 Expo | More to Expect!
- INVITATION! Meet us at the Brazilian Society of Clinical Analysis 2023
- Good News!- Tianlong has helped build up the HCV&HBV detection line for hospitals in northern Thailand!
- PANA9600X Automatic Nucleic Acid Workstation
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more